203 related articles for article (PubMed ID: 16505411)
21. Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.
Lee YJ; Shim HS; Kang YA; Hong SJ; Kim HK; Kim H; Kim SK; Choi SH; Kim JH; Cho BC
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1937-44. PubMed ID: 20237940
[TBL] [Abstract][Full Text] [Related]
22. Screening for epidermal growth factor receptor mutations in lung cancer.
Rosell R; Moran T; Queralt C; Porta R; Cardenal F; Camps C; Majem M; Lopez-Vivanco G; Isla D; Provencio M; Insa A; Massuti B; Gonzalez-Larriba JL; Paz-Ares L; Bover I; Garcia-Campelo R; Moreno MA; Catot S; Rolfo C; Reguart N; Palmero R; Sánchez JM; Bastus R; Mayo C; Bertran-Alamillo J; Molina MA; Sanchez JJ; Taron M;
N Engl J Med; 2009 Sep; 361(10):958-67. PubMed ID: 19692684
[TBL] [Abstract][Full Text] [Related]
23. Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.
Wu SG; Chang YL; Hsu YC; Wu JY; Yang CH; Yu CJ; Tsai MF; Shih JY; Yang PC
Oncologist; 2008 Dec; 13(12):1276-84. PubMed ID: 19060236
[TBL] [Abstract][Full Text] [Related]
24. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.
Balak MN; Gong Y; Riely GJ; Somwar R; Li AR; Zakowski MF; Chiang A; Yang G; Ouerfelli O; Kris MG; Ladanyi M; Miller VA; Pao W
Clin Cancer Res; 2006 Nov; 12(21):6494-501. PubMed ID: 17085664
[TBL] [Abstract][Full Text] [Related]
25. Non-small cell lung cancer-smokers or non-smokers, does it matter?
Barlési F; Nanni-Metellus I; Breen D; Fina F; Astoul P; Martin PM
Lung Cancer; 2009 Mar; 63(3):430-2. PubMed ID: 18789554
[TBL] [Abstract][Full Text] [Related]
26. Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.
Tokumo M; Toyooka S; Ichihara S; Ohashi K; Tsukuda K; Ichimura K; Tabata M; Kiura K; Aoe M; Sano Y; Date H; Shimizu N
Lung Cancer; 2006 Jul; 53(1):117-21. PubMed ID: 16730855
[TBL] [Abstract][Full Text] [Related]
27. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
[TBL] [Abstract][Full Text] [Related]
28. Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
Wu CC; Hsu HY; Liu HP; Chang JW; Chen YT; Hsieh WY; Hsieh JJ; Hsieh MS; Chen YR; Huang SF
Cancer; 2008 Dec; 113(11):3199-208. PubMed ID: 18932251
[TBL] [Abstract][Full Text] [Related]
29. Diffuse micronodular pulmonary metastasis of lung adenocarcinoma predicts gefitinib response in association with epidermal growth factor receptor mutations.
Kobayashi M; Takeuchi T; Bandobashi K; Uemura Y; Ogawa Y; Ohtsuki Y; Taguchi H
Anticancer Res; 2006; 26(2B):1621-6. PubMed ID: 16619582
[TBL] [Abstract][Full Text] [Related]
30. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
[TBL] [Abstract][Full Text] [Related]
31. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
Sequist LV; Martins RG; Spigel D; Grunberg SM; Spira A; Jänne PA; Joshi VA; McCollum D; Evans TL; Muzikansky A; Kuhlmann GL; Han M; Goldberg JS; Settleman J; Iafrate AJ; Engelman JA; Haber DA; Johnson BE; Lynch TJ
J Clin Oncol; 2008 May; 26(15):2442-9. PubMed ID: 18458038
[TBL] [Abstract][Full Text] [Related]
32. Erlotinib in lung cancer - molecular and clinical predictors of outcome.
Tsao MS; Sakurada A; Cutz JC; Zhu CQ; Kamel-Reid S; Squire J; Lorimer I; Zhang T; Liu N; Daneshmand M; Marrano P; da Cunha Santos G; Lagarde A; Richardson F; Seymour L; Whitehead M; Ding K; Pater J; Shepherd FA
N Engl J Med; 2005 Jul; 353(2):133-44. PubMed ID: 16014883
[TBL] [Abstract][Full Text] [Related]
33. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.
Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Lung Cancer; 2006 Oct; 54(1):103-8. PubMed ID: 16890322
[TBL] [Abstract][Full Text] [Related]
34. EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.
Sasaki H; Endo K; Konishi A; Takada M; Kawahara M; Iuchi K; Matsumura A; Okumura M; Tanaka H; Kawaguchi T; Shimizu T; Takeuchi H; Yano M; Fukai I; Fujii Y
Clin Cancer Res; 2005 Apr; 11(8):2924-9. PubMed ID: 15837743
[TBL] [Abstract][Full Text] [Related]
35. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas.
D'Angelo SP; Pietanza MC; Johnson ML; Riely GJ; Miller VA; Sima CS; Zakowski MF; Rusch VW; Ladanyi M; Kris MG
J Clin Oncol; 2011 May; 29(15):2066-70. PubMed ID: 21482987
[TBL] [Abstract][Full Text] [Related]
36. EGFR gene mutations in patients with adenosquamous lung carcinoma.
Powrózek T; Krawczyk P; Ramlau R; Sura S; Wojas-Krawczyk K; Kucharczyk T; Walczyna B; Szumiło J; Szyszka-Barth K; Milecki P; Barinow-Wojewódzki A; Milanowski J
Asia Pac J Clin Oncol; 2014 Dec; 10(4):340-5. PubMed ID: 24575772
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.
Li C; Sun Y; Fang Z; Han X; Fang R; Zhang Y; Pan Y; Zhang W; Ren Y; Ji H; Chen H
J Thorac Oncol; 2011 Jun; 6(6):1016-21. PubMed ID: 21532505
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor mutations as a prognostic factor in Korean patients with advanced lung adenocarcinoma who had not been treated with received epidermal growth factor receptor tyrosine kinase inhibitors.
Kim ST; Choi YJ; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
Chemotherapy; 2011; 57(2):108-14. PubMed ID: 21411993
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.
Boldrini L; Gisfredi S; Ursino S; Camacci T; Baldini E; Melfi F; Fontanini G
J Thorac Oncol; 2007 Dec; 2(12):1086-90. PubMed ID: 18090579
[TBL] [Abstract][Full Text] [Related]
40. Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genes.
Chou WC; Huang SF; Yeh KY; Wang HM; Liu MY; Hsieh JJ; Cheung YC; Chang JW
Jpn J Clin Oncol; 2006 Aug; 36(8):523-6. PubMed ID: 16803841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
